Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; Pittsburgh Institute for Neurodegenerative Diseases (PIND), University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; Pittsburgh Institute for Neurodegenerative Diseases (PIND), University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Neurobiol Dis. 2018 Sep;117:203-210. doi: 10.1016/j.nbd.2018.06.009. Epub 2018 Jun 13.
Mitochondrial encephalomyopathies (MEs) result from mutations in mitochondrial genes critical to oxidative phosphorylation. Severe and untreatable ME results from mutations affecting each endogenous mitochondrial encoded gene, including all 13 established protein coding genes. Effective techniques to manipulate mitochondrial genome are limited and targeted mitochondrial protein expression is currently unavailable. Here we report the development of a mitochondrial-targeted RNA expression (mtTRES) vector capable of protein expression within mitochondria (mtTRES). We demonstrate that mtTRES expressed RNAs are targeted to mitochondria and are capable of being translated using EGFP encoded constructs in vivo. We additionally test mtTRES constructs encoding wild type ATP6 for their ability to rescue an established ATP6Drosophila model of ME. Genetic rescue is examined including tests with co-expression of mitochondrial targeted translational inhibitors TLI-NCL::ATP6 RNAs that function to reduce expression of the endogenous mutant protein. The data demonstrate allotopic RNA expression of mitochondrial targeted wild type ATP6 coding RNAs are sufficient to partially rescue a severe and established animal model of ME but only when combined with a method to inhibit mutant protein expression, which likely competes for incorporation into complex V.
线粒体脑肌病(ME)是由氧化磷酸化过程中关键的线粒体基因发生突变引起的。严重且无法治疗的 ME 是由影响每个内源性线粒体编码基因的突变引起的,包括所有 13 个已建立的蛋白质编码基因。有效的线粒体基因组操作技术有限,靶向线粒体蛋白表达目前尚不可用。在这里,我们报告了一种能够在线粒体中表达蛋白质的线粒体靶向 RNA 表达(mtTRES)载体的开发。我们证明了 mtTRES 表达的 RNA 被靶向到线粒体,并且能够在体内使用 EGFP 编码的构建体进行翻译。我们还测试了 mtTRES 构建体编码野生型 ATP6,以评估其拯救已建立的 ME 果蝇模型的能力。我们检查了遗传拯救,包括共表达靶向线粒体的翻译抑制剂 TLI-NCL::ATP6 RNA 的测试,该 RNA 可降低内源性突变蛋白的表达。数据表明,线粒体靶向野生型 ATP6 编码 RNA 的异位 RNA 表达足以部分拯救严重且已建立的 ME 动物模型,但仅当与抑制突变蛋白表达的方法结合使用时才有效,这可能与竞争纳入复合物 V 有关。